Presented
by

Presented by Oxford Global

Discover PLUS Pass

All Discovery Content

Bringing you the latest research in Drug Discovery In New Modalities, Integration Of DEL, Covalent Inhibitors, Protein Degradation Technologies, Computational Drug Design & Automation Strategies and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Industry Spotlight
Interview with Nicolas Vachicouras, CEO, Neurosoft Bioelectronics: Subdural Brain Interfaces
Talking with Nicolas Vachicouras, CEO of Neurosoft Bioelectronics about their subdural brain interface and its inaugural clinical testing for recording the human brain in the context of an epilepsy resective surgery.
Edited by Tom Cohen |
01 November 2023
Neuroscience Discovery
Insight Article
Challenges in Translational Approaches and Biomarkers in Neurodegeneration
Identifying disease targets, understanding complex biology, and developing effective technologies for target engagement.
Edited by Tom Cohen |
18 August 2023
Neuroscience Discovery
Industry Spotlight
Nasal Spray Shows Remarkable Efficacy in Easing Social Anxiety: Vistagen's Fasedienol Promises New Hope
Positive phase III results propel innovative pherine nasal spray as potential game-changer for millions struggling with social anxiety disorder. Vistagen's novel mechanism of action sparks optimism after previous setback.
Edited by Tom Cohen |
08 August 2023
Neuroscience Discovery
Industry Spotlight
Prothena and Evotec Score Major Deals with Bristol Myers Squibb for Neuroscience Breakthroughs
Prothena will receive $55 million to license its clinical Alzheimer's drug candidate, while Evotec will receive $40 million for its late-stage clinical programs.
Edited by Tom Cohen |
14 July 2023
Neuroscience Discovery
Industry Spotlight
New Study Includes Pain Management Device for Chronic Symptoms of NFL Players
The study will focus on non-invasive vagus nerve stimulation (nVNS) and cannabidiol (CBD) as potential treatments.
Edited by Tom Cohen |
10 July 2023
Neuroscience Discovery
Video Content
Video Q&A
Interview with Valentina Mosienko, Fellow and Lecturer in Neuroscience, University of Bristol
Navigating the neuroscientific pathways for anxiety towards druggable targets.
Edited by Tom Cohen |
03 July 2023
Neuroscience Discovery
Insight Article
Investigating Target Identification and Validation Modelling in Neurodegenerative Disease
The significance of reproducibility, fidelity, and translatability in models, as well as the importance of using multiple models to cross-validate therapeutic targets.
Edited by Tom Cohen |
01 June 2023
Neuroscience Discovery
Industry Spotlight
Gene Discovered to Drive Anxiety Could Prove an Effective Drug Target
The discovery could be a game-changer for the many people that suffer from anxiety related mental health disorders.
Edited by Tom Cohen |
09 May 2023
Neuroscience Discovery
Industry Spotlight
Delix Therapeutics Announces 2 Partners in Neuroscience Drug Discovery Effort
The neuroscience discovery company alter the molecular chemistry of existing psychedelic drugs to maintain their psychoplastogenic properties but remove their hallucinogenic effects.
Edited by Tom Cohen |
15 February 2023
Neuroscience Discovery
Industry Spotlight
Positive Results Achieved from Phase III Trial of MDMA-Assisted Therapy
Significant findings after the Schedule I controlled drug completes Phase III clinical trial for PTSD patients.
Edited by Tom Cohen |
19 January 2023
Neuroscience Discovery

Search by Keyword

Filter by Subject Area

Discovery Series – Subject

Filter by Content Type

Resource Formats (incl. Industry Spotlight)

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.